Peripheral neuropathy diagnostic work-up
Polyneuropathy evaluation · Neurology
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
A structured approach to the patient with sensory, motor or autonomic symptoms of peripheral nerve dysfunction, aiming to define the pattern, identify treatable causes and avoid over-investigation. Most chronic length-dependent neuropathies have identifiable metabolic or toxic causes.
Red flags
- Rapidly progressive or ascending weakness (consider GBS/CIDP)
- Asymmetric or multifocal pattern (vasculitis, MMN)
- Prominent autonomic failure
- Weight loss or systemic features (paraneoplastic/vasculitic)
- Early severe sensory ataxia (ganglionopathy)
Assessment
Differential diagnosis
- Diabetic/metabolic length-dependent neuropathy
- Alcohol or nutritional (B12, thiamine) neuropathy
- Inflammatory neuropathy (CIDP, vasculitic)
- Hereditary neuropathy (CMT)
- Paraproteinaemic neuropathy
- Drug/toxic neuropathy
- Paraneoplastic/sensory ganglionopathy
Investigations
- HbA1c/fasting glucose (and OGTT if impaired)
- Vitamin B12, folate and full blood count
- Thyroid function, renal and liver function
- Serum protein electrophoresis and immunofixation
- ESR/CRP, autoimmune screen if inflammatory suspected
- Nerve conduction studies/EMG to classify axonal vs demyelinating and distribution
- Genetic testing or further tests (anti-MAG, paraneoplastic) guided by pattern
Management
- Characterise the neuropathy by fibre type, distribution and time course
- Distinguish length-dependent symmetrical from asymmetric/multifocal patterns (the latter suggest treatable causes)
- Take a thorough drug, alcohol, occupational and family history
- Order first-line screening bloods for common metabolic causes
- Use nerve conduction studies to classify axonal versus demyelinating
- Pursue demyelinating or asymmetric/rapidly progressive neuropathies aggressively (treatable)
- Add second-line tests (paraprotein work-up, genetics, paraneoplastic) guided by pattern
- Treat the underlying cause where found
- Manage neuropathic pain symptomatically
- Provide foot care, falls prevention and reassurance for idiopathic cases
Drugs & doses
Treat cause-specific (e.g. B12 replacement, glycaemic control)
Amitriptyline 10-75 mg PO nocte for neuropathic pain
Duloxetine 30-60 mg PO daily
Gabapentin 300 mg PO TDS titrated or pregabalin 75-300 mg PO BD
Replace thiamine/B12 where deficient
Disposition
Primary care or outpatient neurology. Urgent referral for rapidly progressive, asymmetric or demyelinating neuropathy.
Complications & pitfalls
- Foot ulceration and Charcot joints
- Falls and injury
- Missed treatable cause
- Chronic neuropathic pain
- Autonomic instability
Exam pearls
- Asymmetric, rapidly progressive or demyelinating neuropathies are the treatable ones; investigate them hard
- A simple metabolic screen identifies most causes of chronic axonal neuropathy
- Up to a quarter remain idiopathic after full work-up; avoid endless testing
- Always ask about alcohol, drugs and family history
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.